换一批Long-term fracture rates seen with continued ibandronate treatment: pooled analysis of DIVA and MOBILE long-term extension studies.
第一作者：
P D,Miller
第一单位：
Colorado Center for Bone Research, 3190 S Wadsworth Blvd, Lakewood, CO, 80227, USA, millerccbr@aol.com.
作者：
医学主题词
投药, 口服(Administration, Oral);老年人(Aged);骨密度(Bone Density);骨密度保护剂(Bone Density Conservation Agents);二膦酸盐类(Diphosphonates);用药计划表(Drug Administration Schedule);欧洲(Europe);女(雌)性(Female);随访研究(Follow-Up Studies);人类(Humans);输注, 静脉内(Infusions, Intravenous);中年人(Middle Aged);骨质疏松, 绝经后(Osteoporosis, Postmenopausal);骨质疏松性骨折(Osteoporotic Fractures);随机对照试验(主题)(Randomized Controlled Trials as Topic);脊柱骨折(Spinal Fractures);美国(United States)
DOI
10.1007/s00198-013-2518-z
PMID
24136103
发布时间
2022-04-08
- 浏览16
Osteoporosis international
349-57页
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文
